Cytokinetics: Specialty Franchise With Aficamten And Ulacamten (NASDAQ:CYTK)

Seeking Alpha Stock

Seeking Alpha Stock3 hrs ago

Cytokinetics: Specialty Franchise With Aficamten And Ulacamten (NASDAQ:CYTK)

CYTK’s Aficamten is easily their main value driver. It has an oHCM PDUFA for December 26, 2025.

18

Target CEO Brian Cornell to Depart Amid Sales Decline

Target CEO Brian Cornell to Depart Amid Sales Decline

America News7 hrs ago

9530

Trump buys more than $100 million in bonds since inauguration, disclosure shows

Trump buys more than $100 million in bonds since inauguration, disclosure shows

Reuters US Politics

Reuters US Politics3 hrs ago

243

Analysis-US tech-stock stumble shows vulnerability in AI trade

Analysis-US tech-stock stumble shows vulnerability in AI trade

Reuters US Business

Reuters US Business4 hrs ago

84

Wall Street tech selloff deepens, European shares steady

Wall Street tech selloff deepens, European shares steady

Reuters US Economy

Reuters US Economy3 hrs ago

1011

Dollar falls as Trump calls on Fed's Cook to resign

Dollar falls as Trump calls on Fed's Cook to resign

Reuters US Economy

Reuters US Economy5 hrs ago

52

Billionaire Stanley Druckenmiller Sold All of His Palantir and Has Piled Into This High

Billionaire Stanley Druckenmiller Sold All of His Palantir and Has Piled Into This High

The Motley Fool

The Motley Fool9 hrs ago

961

CNN Host Abby Phillip Trashes Trump’s Slavery Argument in Emotional Takedown

CNN Host Abby Phillip Trashes Trump’s Slavery Argument in Emotional Takedown

The Daily Beast

The Daily Beast14 hrs ago

37

'He never knows who it is': How 'famed gossip' Trump 'uses his phone as a weapon'

'He never knows who it is': How 'famed gossip' Trump 'uses his phone as a weapon'

1202

49ers make trade with Chiefs for WR amid injuries

49ers make trade with Chiefs for WR amid injuries

Niners NationJust now

33

Looks like you've reached the bottom